Fundación Lindavista del Corazón

Fundación Lindavista del Corazón is a Mexican non-profit organization specializing in cardiovascular research and clinical trial management. Based in Mexico City, the foundation is primarily recognized for its leadership in the "Lindavista Study," a significant longitudinal epidemiological project that tracks cardiovascular risk factors in the Mexican urban population. The organization serves as a clinical research site for international pharmaceutical companies, participating in Phase 3 and Phase 4 trials for major cardiovascular therapies, including statins and antihypertensives. Led by prominent cardiologists, the foundation aims to bridge the gap between clinical research and public health policy in Mexico through evidence-based medicine and community outreach.